ArticleFrontiers in oncology2026
Leveraging deep learning for prognostic stratification of hepatocellular carcinoma using histopathological images.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies, whose prognostic prediction is particularly challenging. Histopathological biomarkers are critical for cancer prognosis assessment. Advancements in artificial intelligence (AI) have made it possible to automate the classification and detection of information from whole-slide pathology images using deep learning. This study aims to utilize AI deep learning to analyze histopathological slides of HCC patients for prognostic stratification, thereby assisting in the development of clinical treatment plans. Methods: The Otsu thresholding method was employed to automatically segment whole-slide images (WSIs) from two HCC datasets, The Cancer Genome Atlas (TCGA) and HCC slides from Ansteel General Hospital. The pathological features of WSIs, extracted by the pretrained CONCH model were utilized as model inputs. Model performance was assessed using the area under the receiver operating characteristic curve and additional metrics. Then Attention Heatmap Visualization was employed to analyze interpretability. The Kolmogorov-Smirnov curve was utilized to stratify patients into distinct risk groups. Survival analysis was performed to evaluate differences in overall survival between distinct risk groups. Univariate and multivariate Cox regression analyses were used to identify key clinical indicators and pathological features as significant predictors. The riskRegression package generated calibration curves comparing predicted versus observed survival outcomes. Calibration curves were quantify the deviation between model-predicted probabilities and actual observed outcomes. Results: A prognostic prediction model was developed using the CLAM self-attention framework based on TCGA dataset, whose generalization capability was verified by histologically stained slide data from a proprietary dataset. The results showed that the model could achieve better migration. Mortality rates demonstrated a progressive increase across ascending risk groups. The risk stratification system possesses potential clinical utility for guiding treatment selection. Forest plots generated demonstrated that the risk stratification system functions as an independent prognostic predictor for HCC. Calibration curve analysis confirmed the predictive accuracy of the model, and this finding from Decision Curve Analysis underscores its superior utility in guiding clinical decision-making. Conclusion: This study developed a prognostic prediction model, whose risk stratification could be an independent prognostic predictor for HCC and a guide for therapeutic decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.